Invasive Infection caused by Neisseria Meningitidis Serogroup B

DrugDrug NameDrug Description
DB15680Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigenThis antigen is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. It is approved for use in individuals 10...
DB10285Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigenNeisseria meningitidis serogroup b recombinant lp2086 b01 protein variant antigen is a sterile vaccine for intramuscular injection indicated for the active immunization to prevent invasive disease caused by Neisseria meningitidis...
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount